Editorial Team

Executive Editor/Editor in Chief

    John W. Oller, Jr., PhD, Professor, Department of Communicative Disorders, University of Louisiana, Lafayette, Louisiana 70504-3645, USA ; theoretician and experimentalist with expertise in the impact of toxicants, trauma (macro or micro), pathogens, and their interactions on human biosignaling systems, mailto: john.oller@louisiana.edu


Senior Editor

   Christopher A. Shaw, PhD, Professor, Department of Ophthalmology, University of British Columbia, 828 W. 10th Ave, Vancouver, BC, V5Z 1L8 expertise in the dynamics of neurological disease and in experimental modeling of the impact of toxicants such as aluminum adjuvants on mouse and human biochemistry; mailto: chris.shaw@ubc.ca


Associate Editors

   Robert M. Davidson, MD, PhD, Certified by the American Board of Nuclear Medicine 1990; also by the American Board of Internal Medicine 1996; Fellow of the American Institute of Stress; expertise in the broad spectrum of human biochemistry, toxicants, pharmaceuticals, vaccines, and medicine

   Gayle DeLong, Associate Professor, Bert W. Wasserman Department of Economics and Finance, City University of New York (CUNY), Baruch College, New York, NY 10021, USA; Author of professional works on vaccine (product) safety relative to "delitigation" and "conflicts of interest"

   Richard C. Deth, PhD, Professor of Pharmacology, Department of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA; expertise in pharmaceutical aspects of vaccine components and toxicology

   Mary S. Holland, MA, JD, General Counsel for Children's Health Defense 2019-present; formerly Director Graduate Lawyering Program, New York University School of Law 2004-2019; Author HPV Vaccine on Trial (Skyhorse, 2018)

   J. J. Kartzinel, MD, Fellow of the American Academy of Pediatrics, Kartzinel Wellness Center; expertise as clinician practitioner treating autism and related neurological disorders

   Robert J. Krakow, JD, Law Office of Robert J. Krakow, Representing the Vaccine Injured in All 50 States

   David L. Lewis, PhD, Professor and Member of the Graduate Faculty, University of Georgia, Research Director at Focus for Health Science for Sale, Skyhorse Publishing Watchung, NJ, Winner of the Sierra Club Distinguished Service Award 2018; and Winner of the US EPA Science Achievement Award 2000; expertise in environmental health risks associated with vaccines 

   James Lyons-Weiler, PhD, Author, CEO, President, Scientist, Editor-in-Chief, Science, Public Health Policy, and the Law; Guest Contributor, Children's Health Defense; The Environmental and Genetic Causes of Autism (Skyhorse 2016); Cures vs. Profits: Successes in Translational Research (World Scientific, 2016); Ebola: An Evolving Story (World Scientific, 2015)

   Stefano Montanari, Doctorate in Pharmacy with a dissertation in michrochemistry;  Director of the Nanodiagnostics Laboratory of Modena since 2004, inventor of caval filtration devices, a prosthetic heart valve, and teacher on caval filtration and nanopathologies in the Interuniversity Masters in Nanotechology of Venice (Ca ’Foscari University, University of Padua, University of Verona), the University of Turin and the European Community; expertise in caval filtration and the prevention of pulmonary thromboembolism; and in pathologies induced by solid, inorganic nanoparticles

   Asgeir Saebo, MS in biology and chemistry University of Bergen, entrepreneur, widely published scientific author/inventor with 35 patents, and former President of American Oil Chemists Society, asgeir@innolipid.com

   Stephanie Seneff, PhD, Senior Research Scientist at the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL), BS biophysics 1968, MS electrical engineering 1980, and PhD computer science in 1985, in addition to her interest in processing of natural sign systems, her current research has focusing on biosignaling systems and ways they are disrupted by toxicants and genetic engineering